US Stock MarketDetailed Quotes

INSM Insmed

Watchlist
  • 69.950
  • +0.910+1.32%
Close Jan 2 16:00 ET
  • 69.950
  • 0.0000.00%
Post 20:01 ET
12.51BMarket Cap-12.60P/E (TTM)

About Insmed Company

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Company Profile

SymbolINSM
Company NameInsmed
Listing DateJun 1, 2000
Founded1988
CEOMr. William H. Lewis
MarketNASDAQ
Employees912
Fiscal Year Ends12-31
Address700 US Highway 202/206
CityBridgewater
ProvinceNew Jersey
CountryUnited States of America
Zip Code08807-3365
Phone1-908-977-9900
Websitehttp://www.insmed.com

Company Executives

  • Name
  • Position
  • Salary
  • William H. Lewis
  • Chairman of the Board, President and Chief Executive Officer
  • 10.41M
  • Michael A. Smith
  • Chief Legal Officer, Senior Vice President, General Counsel and Secretary
  • --
  • Sara Bonstein
  • Chief Financial Officer and Principal Accounting Officer
  • 4.56M
  • Dr. Martina Flammer, M.B.A.
  • Chief Medical Officer
  • 4.22M
  • Roger Adsett
  • Chief Operating Officer
  • 4.01M
  • Drayton Wise
  • Chief Commercial Officer
  • 3.89M
  • S. Nicole Schaeffer
  • Chief People Strategy Officer
  • --
  • David R Brennan
  • Lead Independent Director
  • 345.00K
  • Elizabeth McKee Anderson, M.B.A.
  • Independent Director
  • 310.00K
  • Carol A. Schafer
  • Independent Director
  • 315.00K
  • Leo Lee
  • Independent Director
  • 317.50K
  • David W.J. McGirr, M.B.A.
  • Independent Director
  • 320.00K
  • Dr. Melvin Sharoky,M.D.
  • Independent Director
  • 312.50K
  • Dr. Clarissa Desjardins, PhD
  • Independent Director
  • 315.00K
  • Alfred F. Altomari
  • Independent Director
  • 320.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data